Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymph Node-negative”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Testing effectiveness (Phase 2)Study completedNCT04296162
What this trial is testing

Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)

Who this might be right for
Breast Cancer
Fudan University 182
Large-scale testing (Phase 3)UnknownNCT02249208
What this trial is testing

Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.

Who this might be right for
Breast Cancer
Hospital Universitari Vall d'Hebron Research Institute 150
Large-scale testing (Phase 3)Study completedNCT00312208
What this trial is testing

Docetaxel in Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 3,299
Not applicableStudy completedNCT07211451
What this trial is testing

Axillary Nodal Burden in HER2+ and TNBC

Who this might be right for
Breast Cancer
Gangnam Severance Hospital 1,571
Post-approval studies (Phase 4)UnknownNCT03270007
What this trial is testing

Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Primary Breast Cancer
Tao OUYANG 304
Large-scale testing (Phase 3)UnknownNCT01756170
What this trial is testing

Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients

Who this might be right for
Cervical Cancer
xie congying 200
Testing effectiveness (Phase 2)Study completedNCT00424203
What this trial is testing

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCognitive/Functional EffectsDepression+2 more
UNICANCER 40
Not applicableUnknownNCT03268785
What this trial is testing

Intra-operative Rapid Identification of Lymph Node and Parathyroid

Who this might be right for
Thyroid CancerParathyroid; AbsentHypocalcemia+1 more
Xijing Hospital 200
Not applicableActive Not RecruitingNCT02167490
What this trial is testing

Sentinel Node Vs Observation After Axillary Ultra-souND

Who this might be right for
Early Stage Breast Carcinoma
European Institute of Oncology 1,560
Not applicableStudy completedNCT07659717
What this trial is testing

Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules

Who this might be right for
Papillary Thyroid CancerLymph Node Metastasis
Eleonora Lori, MD 66
Not applicableLooking for participantsNCT06711068
What this trial is testing

Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 8,077
Not applicableStudy completedNCT01622478
What this trial is testing

Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes

Who this might be right for
Breast Cancer
Gangnam Severance Hospital 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05629585
What this trial is testing

Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

Who this might be right for
Breast Cancer
AstraZeneca 1,174
Not applicableLooking for participantsNCT06711055
What this trial is testing

Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 285
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableLooking for participantsNCT01397669
What this trial is testing

Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection

Who this might be right for
HIV-infection
SEARCH Research Foundation 232
Not applicableStudy completedNCT00315159
What this trial is testing

Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.

Who this might be right for
Vulvar Cancer
Women and Infants Hospital of Rhode Island 74
Testing effectiveness (Phase 2)Study completedNCT02138214
What this trial is testing

Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer

Who this might be right for
Stage I Papillary Thyroid CancerStage II Papillary Thyroid CancerStage III Papillary Thyroid Cancer
University of Wisconsin, Madison 117
Large-scale testing (Phase 3)Not Yet RecruitingNCT06996093
What this trial is testing

Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor

Who this might be right for
Breast Cancer
Fudan University 2,508
Large-scale testing (Phase 3)Active Not RecruitingNCT03833154
What this trial is testing

Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 724
Next Page